
Pando Bioscience
Pando Bioscience is a YC Winter 2023 (W23) company. Based in Boston, MA, USA. Team of 5.
About Pando Bioscience
Summary
Pando Bioscience designs and engineers enzymes for pharmaceutical manufacturers and life science tool makers using a generative AI platform backed by an in-house high-throughput screening lab. Its platform evaluates enzyme candidates across multiple performance properties simultaneously, replacing the slow, costly rounds of manual screening and iteration that traditional enzyme development requires. Customers get custom industrial-grade enzymes, including biocatalysts for small-molecule synthesis and DNA-modifying enzymes, without running the discovery process themselves.
Go-to-market
Pharmaceutical companies and life science tool makers engage Pando through service contracts for enzyme development programs, with the company also commercializing its own enzyme products such as its Saiyan-Phi29 polymerase.
From the Y Combinator listing
Gen-AI Designed Enzymes for Pharmaceutical Innovation
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.
Facts
- Healthcare / Healthcare -> Industrial Bio
- Boston, MA, USA
- 5
- Active
- Early
Founders (1)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works